CNSY
Plus Therapeutics, Inc.
NASDAQ · Healthcare · Medical - Pharmaceuticals · US
$2.03
+0.00%Next report
Analyst consensus
- Next report date
- Oct 15, 2026
- EPS estimate
- -$0.92
- Revenue estimate
- $1.3M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$1.31
- EPS estimate
- -$0.88
- Revenue actual
- $411.0K
- Revenue estimate
- $1.1M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 0
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -48.9%
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 14, 2026 | -$0.88 | -$1.31 | Miss -48.86% | $411.0K |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 15, 2026